BioVoice News eMag September 2023 | Page 45

extraction of blood or the need of a phlebotomist .
They can be done by an individual after reading the enclosed instructions in the kit at their home as well . With over 22 years of experience and a vast database accumulated , we generate highly accurate results , boasting a 99.6 % accuracy rate . We have our own patented algorithm called SNAPPY for calculating the Polygenic Risk Score . PRS estimates an individual ’ s genetic risk ( predisposition ) for a trait or condition . PRS takes the sum of all known common variants to calculate an overall genetic risk for a particular condition . Besides , we use our own custom chip which is manufactured by Illumina and ~ 4000 unique markers when compared to other chips on the market . Speaking about data confidentiality , we use Biotracker™ by Ocimum Biosolutions to manage and track information at every stage of the process that ensures compliance while maintaining confidential records of the patients .
How will this technology help in personalized healthcare recommendations ? What about the affordability and availability of the test ?
and dosages based on an individual ' s genetic makeup and being able to suggest the most preferable drug to treat a particular disease for an individual thereby enabling personalized medication regimens with improved efficacy and reduced adverse effects .
The products and technology for our Genome Tests will be made available to the common people of our country through the doctors and hospitals which will be serviced and met by our field force . Our products & tests can also be ordered through our website and we will ensure timely delivery of the testing kit within 48 hours and reverse pick up after the test is conducted and the sample is ready . Price range of the test will be between Rs 8,000 to Rs 16,000 , providing an end to end preventive genetic testing solution . In the first phase of launch we will be focusing on Metro and tier one cities and will be penetrating up to tier 2 and tier 3 towns in next 3-4 years .

“ We invest in ongoing research to improve testing accuracy , identify new genetic markers , and develop cutting-edge technologies ."

BioTech

BIOVOICENEWS . COM 45